Skip to content
Monday, November 9, 2026
Dark BiotechnologyBIOTECH · GENETICS · DEVICES

Biotech News

Dated biotech reporting.

BiotechGeneticsDevicesResearchBiotech NewsTech News
A laboratory technician pipettes clear reagent into a microplate at a white bench under cool teal task lighting.
Biotech News

FDA Approves Shionogi's Xocova as First Oral COVID-19 Post-Exposure Prophylaxis

The FDA has approved Shionogi's Xocova (ensitrelvir) as the first oral post-exposure prophylaxis for COVID-19 in adults and adolescents 12 years of age and older, the company announced on June 1, 2026. The approval, covering use after contact with an individual who has COVID-19, came ahead of…

An engineer adjusting a bioreactor control panel in a facility of glass and brushed steel, teal instrument glow on gloved hands.
Biotech News

Why Biotech Manufacturing Capacity Announcements Are Reshaping U.S. Drug Supply

Eli Lilly said in May 2026 that it will invest an additional $4.5 billion at two of its three Lebanon, Indiana sites, lifting Indiana capital commitments above $21 billion over six years, per the company's announcement. A December 2025 decision to spend more than $6 billion on an Alabama API…

A scientist in a white coat reviewing production data at a stainless bioreactor console under cool teal lighting.
Biotech News

Johnson & Johnson Lifts 2026 Outlook After $25.3 Billion Second Quarter

Johnson & Johnson reported second-quarter 2026 sales of $25.31 billion, up 6.6% year over year, with Innovative Medicine sales of $16.384 billion, up 7.8% — per the earnings release filed with the SEC on July 15, 2026. The company raised full-year guidance to reported sales of $101.1 billion and…

A researcher in safety glasses reviewing trial safety monitoring charts at a cool-lit laboratory bench.
Biotech News

FDA's Expedited IND Comment Window Nears Close After Gene Therapy Holds

FDA's public comment window on its proposed Expedited IND pilot program closes July 22, 2026, per a Federal Register notice published June 24. The docket follows a stretch in which clinical holds hit three high-profile gene therapy programs, including both REGENXBIO MPS trials, per the company's…

An executive in a glass-walled office reviewing documents at a steel desk, laboratory equipment soft-focus behind cool white drapery of light.
Biotech News

What BioNTech's CEO Change Signals About Biotech Leadership Transitions

BioNTech's supervisory board appointed Guido Oelkers, chief executive of Swedish Orphan Biovitrum since 2017, as the company's next CEO on August 3, 2026, with the transition complete by February 1, 2027 at the latest, per the company. He succeeds co-founder Ugur Sahin, and the chief medical…